期刊文献+

急性冠状动脉综合征患者外周血单核细胞核因子κB活性的变化及其意义 被引量:2

Measurement and clinical significance of the activity of nuclear factor B in peripheral blood mononuclear cells in the patients with acute coronary syndrome
下载PDF
导出
摘要 目的探讨核因子κB(NF-κB)在急性冠状动脉综合征(ACS)发病中的作用。方法采用ELISA法检测ACS患者63例、稳定型心绞痛患者38例及正常人20例外周血单核细胞NF-κB的活性,并检测其血清C反应蛋白的浓度。结果ACS患者外周血单核细胞NF-κB活性及血清C反应蛋白浓度明显高于稳定型心绞痛患者和正常人(P<0.01),其中急性心肌梗死患者最高;且两者之间呈明显的正相关性。结论ACS血单核细胞NF-κB活性明显升高,促发急性炎症反应,引起斑块的不稳定,在ACS发生中起着重要作用。 Objective To investigate the role of nuclear factor κB activation in acute coronary syndrome(ACS). Methods 63 patients with ACS(acute myocardial infarction, n = 29;unstable angina pectoris, n =34), 38 cases with stable angina pectoris and 20 normal controls were enrolled. NF -κB activation in peripheral blood mononuclear cells was detemined by ELISA with the TnmsAM NF -κB p65 Kit, and serum C reactive protein (sCRP) concentration was determined. Results The activity of NF -κB in circulating white cells and sCRP concentration in the patients with ACS were significantly higher than those in SAP and normal controls( P 〈0.01 ), especially in AMI.There were positive relationship between the activity of NF - κB and sCRP concentration in the patients with ACS.Conclusion Nuclear factor-κB is markedly activated in patients with ACS, which may be mechanistically involved in the plaque disruption by predisposing acute inflammation reaction, and plays an important role in the pathogenesis of ACS.
出处 《中国急救医学》 CAS CSCD 北大核心 2005年第8期556-558,共3页 Chinese Journal of Critical Care Medicine
关键词 核因子-ΚB 炎症反应 急性冠状动脉综合征 C反应蛋白 Nuclear factor κB(NF-κB) Inflammation reaction Acute coronary syndrome(ACS) C reactive protein(CRP)
  • 相关文献

参考文献8

  • 1Acc/AHA Guideline for the management of patients with unstable angina and not- st- segment elevation myocardial infarction. A report American college of cardiology/American heart association task force or practice guidelines[J]. J Am Coll Cardiol, 2000, 36:970- 1062.
  • 2Vander Wal AC, Becer AE, van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology[J]. Circulation, 1994,89:36 - 44.
  • 3Pearson TA, MenSAPPh GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the center for disease control and prevention and the American heart association[J]. Circulation, 2003,107:499 - 511.
  • 4Wilson SH, Best PJ, Edwards WD, et al. Nuclear factor kappa B immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris[J]. Atherosclerosis, 2002, 160:147- 153.
  • 5Ritchie ME. Nuclear factor- kappaB is selectively and markedly activated in humans with unstable angina pectoris [ J ]. Circulation,1998,98(17): 1707 - 1713.
  • 6SAPPren P, Welgus HG, Kovanen PT. TNF - α and IL - 6 selectively induce expression of 92- Kda gelatinase by human macrophages[J]. J Immunol, 1996, 157:4156-4165.
  • 7Darvies MJ. Reactive oxygen species, metalloproteinases, and plaque stability[J]. Circulation, 1998, 97:2382 - 2383.
  • 8Hemande Z, PreSAPP M, Bustos C, et al. Angiotensin- converting enzyme inhibition prevents arterial nuclear factor- kappa B activation,monocyte chemoattractant protein - 1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis [J].Circulation, 1997,95:1532 - 1541.

同被引文献22

  • 1孙承波,吴宗贵,梁春,任雨笙.急性冠状动脉综合征患者外周血单个核细胞核因子κB活性的测定及临床意义[J].中国动脉硬化杂志,2004,12(6):707-709. 被引量:2
  • 2杨智勇,于海杰,李晓东.急性冠脉综合征患者血清基质金属蛋白酶-9、C反应蛋白、白介素-6的变化及临床意义[J].中国老年学杂志,2007,27(3):259-260. 被引量:7
  • 3杨丽霞,杨玉霞,齐峰,石燕昆,郭传明,王先梅,郭瑞威.冠心病患者外周血核转录因子PPARγ和MMP-9表达的临床研究[J].中国医师杂志,2007,9(4):441-443. 被引量:1
  • 4Hansson GK. Inflammation, atherosclerosis, and coronary artery disease [J]. N Engl J Med, 2005, 352 (16): 1 685-695.
  • 5Mehra VC, Ramgolam VS, Bender JR. Cytokines and cardiovascular disease [J]. J Leukoc Biol, 2005, 78 (4) : 805-818.
  • 6Deguchi JO, Aikawa M, Tung CH, et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo [J]. Circulation, 2006, 114 ( 1 ) : 55-62.
  • 7Derosa G, D'Angelo A, Scalise F, et al. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome [J]. Heart Vessels, 2007, 22 (6) : 361-70.
  • 8Tyagi N, Moshal KS, Sen U, et al. Ciglitazone ameliorates homocysteinemediated mitochondrial transloeation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity [ J ]. Cell Mol Biol, 2006, 52 ( 5 ) : 21-27.
  • 9Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARgamma SAs alternative activation and improves insulin resistance [J]. Nature, 2007, 447 (6): 1 116-120.
  • 10Esposito K, Ciotola M, Carleo D, et al. Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome [J]. Diabetes Care, 2006, 29 (5):1 071-076.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部